Overview


According to FutureWise analysis the market for digital therapeutics in 2023 is US$ 5.93 billion, and is expected to reach US$ 54.08 billion by 2031 at a CAGR of 31.80%.

Digital therapeutics refer to evidence-based interventions delivered through digital technologies to treat, prevent or manage a broad range of physical, mental, and behavioral health conditions. Digital therapeutics products include mobile health apps, wearable devices, software programs, and online platforms that are designed to provide patients with personalized and effective treatment options. Digital therapeutic products are typically designed to target specific health conditions, and they use a range of techniques and approaches to achieve this. These may include cognitive-behavioral therapy, mindfulness meditation, biofeedback, and other evidence-based interventions.

One of the key advantages of digital therapeutics products is that they can be used by patients from the comfort of their homes without the need for in-person visits to healthcare providers. This makes these products more accessible and convenient for patients and can help to reduce the overall cost of healthcare. Digital therapeutics products are also highly customizable, with many products offering personalized treatment plans based on individual patient data. This can include tracking symptoms, medication adherence, and other health-related data, which is used to develop customized treatment plans for each patient. In addition to providing personalized treatment options, digital therapeutics products also offer a high degree of flexibility, allowing patients to use these products on their own schedules and at their own pace. This can be particularly beneficial for patients with busy schedules or limited mobility, as it allows them to receive treatment without having to leave their homes.

FutureWise Market Research has published a report that provides an insightful analysis of Digital Therapeutics Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts projects that Digital Therapeutics Market will experience a significant growth.

According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.
  • Noom, Livongo Health
  • WellDoc
  • Pear Therapeutics
  • Omada Health
  • Proteus Digital Health
  • Propeller Health
  • Akili Interactive Labs
  • Better Therapeutics
  • Happify
  • Kaia Health
  • Mango Health
  • Click Therapeutics
  • Canary Health
  • Wellthy Therapeutics
  • Cognoa
  • Ayogo Health
  • Mindstrong Health
  • 2Morrow
  • Ginger

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in Digital Therapeutics Market:

In April 2021, Wellbeing Digital Solutions was purchased by Philips. WDS is a startup that creates digital treatments to enhance patient involvement and results in chronic diseases. With the purchase, Philips was empowered to broaden the scope of its digital health offerings and its capacity for remote care and chronic illness management.

The digital therapeutics market is a rapidly growing sector within the healthcare industry that is focused on the use of digital technologies to treat and manage various health conditions. The primary drivers of growth in the digital therapeutics market include the rising prevalence of chronic illnesses, rising healthcare expenditure, and the growing demand for more effective and personalized treatments. Additionally, advancements in technology and the increasing adoption of smartphones and other mobile devices have made it more convenient for individuals to access and utilize digital therapeutic products. One of the key dynamics of the digital therapeutics market is the shift towards a more patient-centric approach to healthcare. This trend is driving the development of digital therapeutics products that are designed to be more user-friendly, accessible, and customizable. As a result, many digital therapeutics companies are focusing on developing products that are tailored to the specific needs and preferences of individual patients. Another important dynamic in the digital therapeutics market is the increasing emphasis on data analytics and artificial intelligence. These technologies are being used to analyze patient data, identify trends and patterns, and develop more personalized treatment plans. This is helping to improve the accuracy and effectiveness of digital therapeutics products and is driving innovation in the industry.

The digital therapeutics market is also being shaped by regulatory developments, with many countries and regions introducing regulations and guidelines to govern the development and use of these products. This is creating a more standardized and transparent environment for the industry and is helping to build trust and confidence among healthcare providers and patients.

By Sales Channel

  • B2C
    •   Patients
    •   Caregivers
  • B2B
    •   Providers
    •   Payers
    •   Employers
    •   Pharmaceutical Companies
    •   Other Buyers

By Application

  • Preventive Applications
    •   Prediabetes
    •   Obesity
    •   Nutrition
    •   Lifestyle Management
    •   Other Preventive Applications
  •  Treatment/Care Related Applications
    •   Diabetes
    •   CNS Disorders
    •    Chronic Respiratory Disorders
    •   Musculoskeletal Disorders
    •   Other Treatment/Care-related Applications

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered the highest share in the market in 2022. Due to the region's early acceptance of new technologies and increased financial expenditure, North America is anticipated to dominate the global market. Increasing government investment, venture capitalists, mergers, and acquisitions are all expected to fuel the market. For instance, Philips announced in February 2021 that it had acquired BioTelemetry, Inc., one of the top US companies offering remote cardiac diagnosis and monitoring. Product acceptance is yet another element influencing the market's expansion. Additionally, based on sales channel; the B2B segment held the biggest share of the global market in 2022.
  • Tier 1 players- established companies in the market with major market share
  • Tier 2 players
  • New Entrants
  • Emerging players which are growing rapidly
  • Growth prospects
  • SWOT analysis
  • Key market trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the global digital therapeutics market By Sales Channel, By Application and By Region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
  • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com.

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Digital Therapeutics Market Variables, Trends and Scope

    •      1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Type Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Digital Therapeutics Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Digital Therapeutics Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Type Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Type Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Digital Therapeutics Market, By Sales Channel Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. B2C
         1.1. Patients
         1.2. Caregivers
        2. B2B
         2.1. Providers
         2.2. Payers
         2.3. Employers
         2.4. Pharmaceutical Companies
         2.5. Other Buyers

  • 8.   Digital Therapeutics Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Preventive Applications
         1.1 . Prediabetes
         1.2 . Obesity
         1.3 . Nutrition
         1.4 . Lifestyle Management
         1.5 . Other Preventive Applications
        2. Treatment/Care Related Applications
         2.1. Diabetes
         2.2. CNS Disorder
         2.3. Chronic Respiratory Disorders
         2.4. Musculoskeletal Disorders
         2.5. Other Treatment/Care-related Applications

  • 9.   North America Digital Therapeutics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 10.   Latin America Digital Therapeutics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 11.   Europe Digital Therapeutics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 12.   Asia Pacific Digital Therapeutics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 13.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 14.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

    •   1. Noom and Livongo Health
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Omada Health
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. WellDoc
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Pear Therapeutics
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Proteus Digital Health
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Propeller Health
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Akili Interactive Labs
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Better Therapeutics
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Happify
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Kaia Health
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Mango Health
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Click Therapeutics
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Canary Health
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. Wellthy Therapeutics
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. Cognoa
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
        16. Ayogo Health
         16.1. Company Overview
         16.2. Product Portfolio
         16.3. SWOT Analysis
         16.4. Financial Overview
         16.5. Strategic Overview
        17. Mindstrong Health
         17.1. Company Overview
         17.2. Product Portfolio
         17.3. SWOT Analysis
         17.4. Financial Overview
         17.5. Strategic Overview
        18. 2Morrow
         18.1. Company Overview
         18.2. Product Portfolio
         18.3. SWOT Analysis
         18.4. Financial Overview
         18.5. Strategic Overview
        19. Ginger
         19.1. Company Overview
         19.2. Product Portfolio
         19.3. SWOT Analysis
         19.4. Financial Overview
         19.5. Strategic Overview

  • 16.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 17.   FutureWise SME Key Takeaway Points for Client

Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11